Who We Are
What We Do
Our Client Base
Bellerophon Therapeutics Submits Investigational New Drug Application to Study INOpulse® Inhaled Nitric Oxide Therapy for the Treatment of COVID-19
April 8, 2020
COVID-19: Redefining Our Present and Future Attitudes Towards Hygiene
April 1, 2020
Bellerophon Therapeutics Announces First Patient Treated with INOpulse® Inhaled Nitric Oxide Therapy for COVID-19
March 30, 2020
AgNovos Healthcare Receives Breakthrough Designation for Spine Device
March 26, 2020
Center for Organ Recovery & Education Receives Katie Coolican-Nicholas Miller Donor Care Award for Excellence in Donor Family Support
March 24, 2020
FDA Grants Bellerophon Emergency Expanded Access for INOpulse® for the Treatment of COVID-19 Virus
March 20, 2020
Kuros strengthens orthobiologics patent portfolio
March 18, 2020
Bellerophon Announces Agreement with the FDA on its Planned Pivotal Phase 3 Study for the Treatment of Pulmonary Hypertension Associated with Pulmonar...
March 10, 2020
AnGes and Osaka University launch joint DNA vaccine development against Coronavirus Disease 2019 (COVID-19)
March 5, 2020
Study showing treatment of osteoporotic vertebrae with LOEP enhances biomechanical properties is published in Archives of Orthopaedic and Trauma Surge...
March 2, 2020
Dr. Scott Bruder to Lecture on Biologic Product Development at the North American Spine Society's Biologics Intervention Meeting
August 30, 2019
Dr. Scott Bruder to Lecture on FDA Guidelines and Compliance at Vail's Steadman Philippon Regenerative Medicine Summit
August 22, 2019
Dr. Scott Bruder to Lecture on Selection of Appropriate Clinical Targets for Regenerative Medicine at the 4th Annual Mid-Atlantic Advanced Biomanufact...
February 7, 2020
Click here for full article.
I'm busy working on my blog posts. Watch this space!
April 2020 (2)
March 2020 (8)
February 2020 (11)
January 2020 (9)
December 2019 (3)
November 2019 (5)
October 2019 (7)
September 2019 (7)
August 2019 (4)
July 2019 (1)